CoChat

Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis

Open access

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

Abstract

A new, safe, and effective vaccine against poliovirus is urgently needed not only to complete the eradication of the virus but also to be used in the future to prevent possible virus reemergence in a postpolio world. Currently, new formulations of the oral vaccine, as well as improvements to the inactivated vaccine, are being explored. In this study, we designed a viral vector with mucosal tropism that expresses poliovirus capsid proteins. Thus, poliovirus VLPs are produced in vivo , in the cells of a vaccine recipient, and are presented to the immune system in the context of vector virus replication, stimulating the development of systemic and mucosal immune responses. Such an approach allows the development of an affordable and safe vaccine that does not rely on the full-length poliovirus genome at any stage.

Overview

Integrity signals

Registry

Crossref · 10.1128/jvi.00976-18

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 77 references

Research works printed but not linked: 3

  1. Lamb RA, Parks GD. 2007. Paramyxoviridae: the viruses and their replication, p 1449–1496. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
  2. Samal SK. 2011. The biology of paramyxoviruses, p 69–114. Caister Academic Press, Norfolk, United Kingdom.
  3. . 1997. Manual for the virological investigation of polio. World Health Organization, Geneva, Switzerland.

Cited by

See all 29

Metadata

Authors
Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A.
Affiliations
  • Virginia–Maryland College of Veterinary Medicine (US)
  • Center for Biologics Evaluation and Research (US)
Venue
Journal of Virology
Published
2018-09
Volume
92
Issue
17
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2808156154
Cited by
29
References
78
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 10 · 2021: 1 · 2020: 4
FWCI
0.97
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Journal of Virology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
HHS | National Institutes of Health (R21AI15383A)
Topics
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
Newcastle disease virus vector, polio vaccine, poliovirus, virus-like particles, capsid protein, mucosal immunity, systemic immune response, live attenuated vaccine, vaccine safety
MeSH terms
Animals, Antibodies, Viral, Genetic Vectors, Guinea Pigs, Immunoglobulin A, Immunoglobulin G, Newcastle disease virus, Poliomyelitis, Poliovirus Vaccine, Inactivated, Vaccination, Poliovirus, Immunity, Mucosal, Poliovirus Vaccines, Capsid Proteins, Vaccines, Virus-Like Particle, Vaccines, Live, Unattenuated

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis. https://app.cochat.ai/papers/10.1128/jvi.00976-18
The paper
Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A. (2018). Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis. Journal of Virology. https://doi.org/10.1128/jvi.00976-18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.